AUS
NZ
UK
CA
USA
IND
Healthcare
Could This Autoimmune Breakthrough Strengthen Johnson & Johnson?
June 04, 2026 07:38 AM PDT| By Anmol KhazanchiEncouraging autoimmune trial findings have strengthened focus on Johnson & Johnson’s research pipeline as the company advances innovative therapies targeting diseases with substantial unmet medical needs.
Medtronic’s MiniMed Move Signals A Sharper Focus
June 04, 2026 07:15 AM PDT| By Anmol KhazanchiMedtronic’s MiniMed separation sharpens its medical technology portfolio, placing greater focus on core device platforms, innovation spending, acquisition strategy, regulatory execution and long-term capital discipline.
Big Pharma Races To Outrun The Patent Cliff
June 03, 2026 03:40 PM PDT| By Anmol KhazanchiBig pharma faces recurring patent cliffs as aging medicines lose exclusivity, making pipelines, approvals, acquisitions, and portfolio renewal essential to long-term revenue stability across major pharmaceutical companies.
UnitedHealth Faces Cost Pressure As Managed Care Scrutiny Builds
June 03, 2026 03:31 PM PDT| By Anmol KhazanchiUnitedHealth remains central to managed care as medical costs, policy scrutiny, and margin discipline shape the company’s outlook while healthcare coverage stays essential through changing economic conditions.
Healthcare Plays Defense And Growth As Policy Risks Remain
June 03, 2026 03:25 PM PDT| By Anmol KhazanchiHealthcare blends steady demand with breakthrough therapies, giving the sector both defensive strength and growth appeal across insurers, drugmakers, obesity care, oncology, and medical innovation.
Is Johnson & Johnson's Pullback Creating Fresh Attention?
June 03, 2026 10:35 AM PDT| By Anmol KhazanchiHealthcare innovation, diversified operations and earnings resilience continue shape discussions surrounding major pharmaceutical leaders as market participants assess valuation, growth visibility and long-term business fundamentals.
Why Is S&P 500 Attention Turning to Medtronic's Guidance Cut?
June 03, 2026 09:32 AM PDT| By Anmol KhazanchiMedtronic reports updated guidance, highlights performance across major medical technology segments, and continues product expansion efforts while maintaining presence in the S&P 500 Index.
Why Is Russell 1000 Attention Shifting to Merck’s Animal Health Unit?
June 03, 2026 09:31 AM PDT| By Anmol KhazanchiA lawsuit involving Merck highlights Animal Health disclosure allegations, drawing Russell 1000 Index attention to competition, product adoption trends, market position, and reporting.
Why Boston Scientific Faces New Questions Across Healthcare
June 02, 2026 09:45 PM PDT| By Anmol KhazanchiBoston Scientific is drawing attention amid evolving healthcare technology trends, structural heart developments, and broader changes across the medical device industry.
Why Established Healthcare Companies Remain Central to the Sector
June 02, 2026 10:21 AM PDT| By Anmol KhazanchiEstablished healthcare companies anchor the sector through diversified pipelines, steady cash flows and consistent demand, balancing innovation-driven growth areas within healthcare.
Why Is Biotech Attracting Attention From AI Driven Innovation
June 02, 2026 10:19 AM PDT| By Anmol KhazanchiBiotechnology attracts renewed interest as artificial intelligence shapes drug discovery discussions, combining healthcare fundamentals with emerging technology-driven innovation themes.
Why Is a Treatment Boom Driving Healthcare Stocks Higher
June 02, 2026 10:17 AM PDT| By Anmol KhazanchiExpanding treatment demand has elevated healthcare leadership, reshaped competition, and strengthened sector momentum across evolving pharmaceutical markets.
What Keeps Merck At The Center Of Global Healthcare Innovation?
June 02, 2026 12:05 AM PDT| By Anmol KhazanchiMerck continues attracting attention through its pharmaceutical research, vaccine portfolio, oncology activities, and broad participation in global healthcare markets.
Top US Health Insurance Stocks In S&P 500
June 01, 2026 05:38 PM PDT| By Anmol KhazanchiUS health insurance stocks continue to navigate medical cost pressure, Medicare Advantage challenges, regulatory changes, and evolving care models, while major managed care companies remain central to the U.S. healthcare landscape.
Top US Big Pharma Stocks Shaping Healthcare’s Next Era
June 01, 2026 01:15 PM PDT| By Anmol KhazanchiMajor pharmaceutical companies continue driving healthcare innovation through drug development, expanding therapeutic portfolios, and strategic acquisitions while navigating patent expirations, pricing pressures, and evolving regulatory frameworks.
Why Is S&P 500 Attention on Revvity After Earnings Miss?
June 01, 2026 09:42 AM PDT| By Anmol KhazanchiRevvity drew attention through earnings developments, research tools, laboratory innovation, diagnostic technologies, and broader life sciences trends shaping the S&P 500 Index.
Why Did NYSE Composite Investors Track GSK Voting Rights Update?
June 01, 2026 09:16 AM PDT| By Anmol KhazanchiGSK released a voting rights update detailing share capital structure, treasury shares, regulatory disclosures, and corporate governance transparency across NYSE Composite companies.
Why Is NYSE Composite Spotlighting AMN’s Strong Earnings Growth?
June 01, 2026 09:00 AM PDT| By Anmol KhazanchiAMN Healthcare Services remained in focus following quarterly results as healthcare staffing, workforce technology, and broader healthcare services activity influenced NYSE Composite performance.
Why Pfizer's Oncology Strategy Is Drawing Renewed Attention
June 01, 2026 12:20 AM PDT| By Anmol KhazanchiPfizer continues attracting attention as oncology research, strategic collaborations, and clinical development activities influence the global pharmaceutical industry.
Can S&P 500 Access Expansion Drive Eli Lilly Obesity Growth?
May 31, 2026 08:46 AM PDT| By Anmol KhazanchiEli Lilly’s expanding obesity treatment access, clinical research activity, and healthcare coverage developments highlight evolving pharmaceutical sector dynamics within the S&P 500 Index.
